FoxOs: Unifying links between oxidative stress and skeletal homeostasis

被引:49
作者
Kousteni S. [1 ,2 ]
机构
[1] Department of Medicine, College of Physicians and Surgeons, Columbia University, New York
[2] Russ Berrie Medical Sciences Pavilion, New York, NY 10032
关键词
Aging; FoxOs; Osteoblasts; Osteoclasts; Oxidative stress; Proliferation; Skeleton; Survival;
D O I
10.1007/s11914-011-0054-3
中图分类号
学科分类号
摘要
Several mechanisms contribute to the decline of all physiologic functions during aging. As a consequence, disease incidence increases with age. Central to this multifactorial process is the increase in oxidative stress levels, which correlates with age-related disease pathogenesis in animal models and in humans. Accordingly, skeletal aging and aging-related bone diseases are also associated with accumulation of reactive oxygen species. In a variety of organs, including the skeleton, mutations in components of antioxidant defense pathways have been found to lead to progressive degenerative diseases. The molecules involved are highly conserved, can sense and respond to increases in oxidative stress levels, alterations in energy status, DNA and protein damage, and they all have a common transcriptional target, the FoxO family of Forkhead transcription factors. Oxidative stress promotes both the transcriptional activity and protein stability of FoxOs. In turn, activated FoxOs promote antioxidant defense by controlling the expression of genes involved in the oxidative stress response, DNA repair, cell cycle, and apoptosis. Among the FoxO isoforms, FoxO1 in osteoblasts uses a previously unrecognized mechanism to preserve redox balance by promoting protein synthesis and subsequently inhibiting cell cycle arrest. This evidence indicates that FoxO1 integrates and orchestrates responses to different stress signals to maintain bone cell function and preserve skeletal homeostasis. © 2011 Springer Science+Business Media, LLC.
引用
收藏
页码:60 / 66
页数:6
相关论文
共 73 条
[1]
Bishop N.A., Lu T., Yankner B.A., Neural mechanisms of ageing and cognitive decline, Nature, 464, 7288, pp. 529-35, (2010)
[2]
Yankner B.A., Lu T., Loerch P., The aging brain, Annual Review of Pathology: Mechanisms of Disease, 3, pp. 41-66, (2008)
[3]
Finkel T., Radical medicine: Treating ageing to cure disease, Nature Reviews Molecular Cell Biology, 6, 12, pp. 971-976, (2005)
[4]
Haigis M.C., Yankner B.A., The aging stress response, Mol Cell., 40, 2, pp. 333-44, (2010)
[5]
Wanagat J., Dai D.F., Rabinovitch P., Mitochondrial oxidative stress and mammalian healthspan, Mech Ageing Dev., 131, 78, pp. 527-35, (2010)
[6]
Uranga R.M., Bruce-Keller A.J., Morrison C.D., Fernandez-Kim S.O., Ebenezer P.J., Zhang L., Et al., Intersection between metabolic dysfunction, high fat diet consumption, and brain aging, J Neurochem., 114, 2, pp. 344-61, (2010)
[7]
Dai D.F., Rabinovitch P.S., Cardiac aging in mice and humans: The role of mitochondrial oxidative stress, Trends Cardiovasc Med., 19, 7, pp. 213-20, (2009)
[8]
Madamanchi N.R., Vendrov A., Runge M.S., Oxidative stress and vascular disease, Arteriosclerosis, Thrombosis, and Vascular Biology, 25, 1, pp. 29-38, (2005)
[9]
Rosen D.R., Siddique T., Patterson D., Figlewicz D.A., Sapp P., Hentati A., Donaldson D., Goto J., O'Regan J.P., Deng H.-X., Rahmani Z., Krizus A., McKenna-Yasek D., Cayabyab A., Gaston S.M., Berger R., Tanzi R.E., Halperin J.J., Herzfeldt B., Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis, Nature, 362, 6415, pp. 59-62, (1993)
[10]
Mlakar S.J., Osredkar J., Prezelj J., Marc J., The antioxidant enzyme GPX1 gene polymorphisms are associated with low BMD and increased bone turnover markers, Dis Markers., 29, 2, pp. 71-80, (2010)